Summary:
Experience Moderate to Severe Active Ulcerative Colitis?
If so, you may qualify for a clinical research study of an investigational drug for ulcerative colitis at Global Medical Research.
Qualified Participants Must:
Must have moderate to severe active ulcerative colitis and*:- Be between 18 and 80 years of age
- Have a diagnosis of UC for two or more months prior to joining the study
- Have not responded or have had a loss of response to one of the following types of treatment during the past five years: Immunomodulators, TNF- (alpha) antagonists, or Corticosteroids
*Other conditions may apply. You cannot participate if you have a history of Crohns disease, indeterminate colitis, or the presence or history of fistula consistent with Crohns disease.
Qualified Participants May Receive:
Qualified participants will receive:
Study-related drug at no cost
Study-related medical exams at no cost
Compensation up to ($690) for time and travel